Table 3 Risk estimate for AML in the two studied genes
AML | Control | OR | 95% CI | p-value | |
|---|---|---|---|---|---|
CYP2B6 gene polymorphism | |||||
GG | 23 (46%) | 36 (72%) | 3.0 | 1.3-6.9 | 0.008 |
GT + TT | 27 (54%) | 14 (28%) | |||
CYP3A4 gene polymorphism | |||||
AA | 31 (62%) | 43 (86%) | 3.8 | 1.4-10.1 | 0.006 |
AG + GG | 19 (38%) | 7 (14%) | |||
CYP2B6 gene polymorphism + CYP3A4 gene polymorphism | |||||
Combined | 14 (43.7%) | 1 (5.0%) | 14.8 | 1.8-124.2 | 0.003 |
Single | 18 (56.3%) | 19 (95.0%) | |||